Clinical Trial Update: Adebrelimab With Chemoradiotherapy and Surgery for G/GEJ [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Adebrelimab in combination with chemoradiotherapy and surgery for gastroesophageal junction and gastric adenocarcinoma is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Jiangsu Cancer Institute & Hospital | Conditions: Gastroesophageal Adenocarcinoma, Gastric Adenocarcinoma | Phase 2 | Status: RECRUITING